Medicover AB (LTS:0RPS) Beneish M-Score: -2.81 (As of Jul. 04, 2026)


LTS:0RPS Medicover AB LTS:0RPS
89 GF Score
Price kr238.00
GF Value kr233.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Beneish M-Score?

Medicover AB LTS:0RPS +0.42% 89 Beneish M-Score is -2.81 as of Jul. 04, 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr233.91 (Fairly Valued). The stock has 5 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Medicover AB ranks better than 69.26% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.81 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medicover AB's Beneish M-Score or its related term are showing as below:

LTS:0RPS' s Beneish M-Score Range Over the Past 10 Years
Min: -3.34   Med: -2.79   Max: -2.33
Current: -2.81

During the past 12 years, the highest Beneish M-Score of Medicover AB was -2.33. The lowest was -3.34. And the median was -2.79.


Medicover AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medicover AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Beneish M-Score Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.57 -2.50 -3.34 -2.95 -2.91

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.95 -2.86 -2.86 -2.91 -2.81

LTS:0RPS vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Medicover AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medicover AB's Beneish M-Score falls into.


LTS:0RPS
89GF Score
Medicover AB LTS:0RPS
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medicover AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0699+0.528 * 0.9407+0.404 * 1.1032+0.892 * 1.0814+0.115 * 1.0482
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9175+4.679 * -0.104254-0.327 * 1.0259
=-2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was kr3,876 Mil.
Revenue was 6723.464 + 6656.714 + 6508.086 + 6571.408 = kr26,460 Mil.
Gross Profit was 1585.54 + 1491.966 + 1526.914 + 1564.936 = kr6,169 Mil.
Total Current Assets was kr5,514 Mil.
Total Assets was kr26,117 Mil.
Property, Plant and Equipment(Net PPE) was kr11,034 Mil.
Depreciation, Depletion and Amortization(DDA) was kr2,394 Mil.
Selling, General, & Admin. Expense(SGA) was kr4,353 Mil.
Total Current Liabilities was kr7,418 Mil.
Long-Term Debt & Capital Lease Obligation was kr11,817 Mil.
Net Income was 238.046 + 204.588 + 214.516 + 210.347 = kr867 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was 783.076 + 1089.32 + 1086.881 + 631.04 = kr3,590 Mil.
Total Receivables was kr3,350 Mil.
Revenue was 6332.726 + 6393.155 + 5992.082 + 5750.353 = kr24,468 Mil.
Gross Profit was 1453.646 + 1388.366 + 1284.018 + 1240.604 = kr5,367 Mil.
Total Current Assets was kr5,273 Mil.
Total Assets was kr23,835 Mil.
Property, Plant and Equipment(Net PPE) was kr10,645 Mil.
Depreciation, Depletion and Amortization(DDA) was kr2,447 Mil.
Selling, General, & Admin. Expense(SGA) was kr4,388 Mil.
Total Current Liabilities was kr6,194 Mil.
Long-Term Debt & Capital Lease Obligation was kr10,918 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3875.524 / 26459.672) / (3349.849 / 24468.316)
=0.146469 / 0.136906
=1.0699

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5366.634 / 24468.316) / (6169.356 / 26459.672)
=0.21933 / 0.233161
=0.9407

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5513.844 + 11034.15) / 26117.243) / (1 - (5273.438 + 10645.465) / 23834.536)
=0.366396 / 0.332108
=1.1032

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=26459.672 / 24468.316
=1.0814

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2446.617 / (2446.617 + 10645.465)) / (2394.126 / (2394.126 + 11034.15))
=0.186878 / 0.17829
=1.0482

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4353.203 / 26459.672) / (4387.756 / 24468.316)
=0.164522 / 0.179324
=0.9175

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((11817.226 + 7418.215) / 26117.243) / ((10918.229 + 6193.606) / 23834.536)
=0.736504 / 0.717943
=1.0259

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(867.497 - 0 - 3590.317) / 26117.243
=-0.104254

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medicover AB has a M-score of -2.81 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.81 mean?
Medicover AB (LTS:0RPS) has a Beneish M-Score of -2.81 as of Jul. 04, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medicover AB and its competitors. According to the industry distribution chart, Medicover AB ranks #194 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 30.7%.
Is Medicover AB's Beneish M-Score too high?
Medicover AB's current Beneish M-Score is -2.81. Based on the distribution chart, Medicover AB ranks #194 out of 631 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #194 out of 631 companies for Beneish M-Score. This puts Medicover AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medicover AB and its competitors. Medicover AB's current Beneish M-Score is -2.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.91, compared to a current price of kr238.00 — trading 1.7% above its estimated fair value. The current Beneish M-Score is -2.81. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Beneish M-Score is -2.81 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr238.00 is trading 1.7% above its estimated GF Value™ of kr233.91. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Beneish M-Score: -2.81
  • GF Value™: kr233.91 vs. price of kr238.00 (1.7% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score

Get the complete analysis for LTS:0RPS

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr238.00
Price
kr233.91
GF Value